Breath testing study for small bowel bacterial overgrowth
Part of Digestive system clinical trials.
This study checks whether breath tests can help identify small intestinal bacterial overgrowth in people with reflux-like symptoms (heartburn or regurgitation). If you qualify, you may be asked to avoid certain medicines and treatments for a short time so the test results are accurate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You mainly have reflux symptoms like heartburn or regurgitation
- You can understand the study and sign informed consent
- You have NOT been diagnosed with small intestinal bacterial overgrowth (SIBO) before
- You have not taken acid-suppressing medicines (PPIs or H2 blockers) in the last 3 months
- You have not taken antibiotics in the last month and have not had most stomach or bowel surgeries
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses simple breath tests to check for bacterial overgrowth in the gut, which may cause symptoms like bloating, diarrhea, or weight loss in people with chronic pancreatitis or after partial pancreas removal. It aims to find out if treating this bacterial issue could improve symptoms.
This is a research registry that collects small-bowel fluid samples from people being tested for “SIBO” (an overgrowth of bacteria in the small intestine). It aims to describe what bacteria are present and how results differ between people with suspected SIBO and others having similar tests for other reasons.
This study looks at whether people with autoimmune gastritis (a stomach condition) are more likely to have small intestinal bacterial overgrowth (SIBO), which can cause bloating and other symptoms. It uses a simple breath test and questionnaires.
This trial studies a simple breath test to detect cancers of the digestive system, including the esophagus, stomach, liver, pancreas, and colon. It is for people who have been referred by their doctor for tests because they have symptoms that might be caused by cancer.
This trial studies whether a breath test (hydrogen/methane lactose testing) can predict who with IBS will improve on a lactose-free diet. If you have moderate-to-severe IBS and regularly eat lactose-containing foods, the test result may help tailor your diet approach.
This study tests a device called AIRE-2 that analyzes your breath to see if it can help manage IBD symptoms. It is for people with IBD who are in remission but still have IBS-like symptoms like belly pain or bloating.
Hear when a new Gastroesophageal Reflux trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.